HONG KONG–(BUSINESS WIRE)–#insurance–Given Super Typhoon Nanmadol�s reduced strength upon landfall and the parts of Japan affected, AM Best expects insured losses to be manageable for Japans non-life insurers.
In its Bests Commentary, Manageable Impact of Super Typhoon Nanmadol on Insured Losses, AM Best states that large insurers in Japan are well-capitalized and their comprehensive reinsurance programs will protect them from a significant impact on capital. If insured losses are not high from the event, which mainly affected the agriculture-heavy island of Kyushu, the amount of losses passed to reinsurers may not be significant. However, secondary perils such as hurricane-induced flooding, storm surges and landslides are not modeled to the same extent as primary perils, and loss creep was an issue for insurers after 2018s Typhoon Jebi. Nevertheless, some of the necessary conditions leading to loss creep a few years ago may not necessarily apply given some of the initiatives major insurers have implemented in recent years.
The commentary also notes that any catastrophic event after above-average catastrophe years may cause reinsurers to revisit their risk appetite and underwriting.
To access the full copy of this commentary, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=324320.
AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.
Copyright © 2022 by AM Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
Contacts
Charles Chiang
Fiancial Analyst
+852 2827 3427
charles.chiang@ambest.com
Jason Shum
Associate Director, Analytics
+852 2827 3424
jason.shum@ambest.com
Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com
Al Slavin
Communications Specialist
+1 908 439 2200, ext. 5098
al.slavin@ambest.com
Patent has broad claims for the Reduction of Acute Kidney Injury in Patients with Chronic…
Live showcase of remote robotic capability for emergent interventional procedures HOUSTON--(BUSINESS WIRE)--XCath, an early-stage medical…
HANGZHOU, China--(BUSINESS WIRE)--MOGU Inc. (NYSE: MOGU) (“MOGU” or the “Company”), a KOL-driven online fashion and…
Company recognized for high levels of trust, respect, credibility, fairness, pride and camaraderie SYDNEY--(BUSINESS WIRE)--$S…
Patient advocacy groups form global collaborative to address unmet needs in CTCL, with support from…
Important milestone towards realization of 100 MW-class alkaline-water electrolysis systems TOKYO & NEW YORK &…
